1. Academic Validation
  2. The first synthesis of the antiangiogenic homoisoflavanone, cremastranone

The first synthesis of the antiangiogenic homoisoflavanone, cremastranone

  • Org Biomol Chem. 2014 Oct 21;12(39):7673-7. doi: 10.1039/c4ob01604a.
Bit Lee 1 Halesha D Basavarajappa Rania S Sulaiman Xiang Fei Seung-Yong Seo Timothy W Corson
Affiliations

Affiliation

  • 1 College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, South Korea. syseo@gachon.ac.kr.
Abstract

An antiangiogenic homoisoflavanone, cremastranone, was synthesized for the first time. This scalable synthesis, which includes selective demethylation, could be used to develop lead molecules to treat angiogenesis-induced eye diseases. Synthetic cremastranone inhibited the proliferation, migration and tube formation ability of human retinal microvascular endothelial cells, important steps in pathological angiogenesis.

Figures
Products